GSK

1,853.5

-2.22%↓

STJ

1,193.5

-2.17%↓

HIK

1,404.5

+1.08%↑

HILS

2,490

-3.11%↓

GSK

1,853.5

-2.22%↓

STJ

1,193.5

-2.17%↓

HIK

1,404.5

+1.08%↑

HILS

2,490

-3.11%↓

GSK

1,853.5

-2.22%↓

STJ

1,193.5

-2.17%↓

HIK

1,404.5

+1.08%↑

HILS

2,490

-3.11%↓

GSK

1,853.5

-2.22%↓

STJ

1,193.5

-2.17%↓

HIK

1,404.5

+1.08%↑

HILS

2,490

-3.11%↓

GSK

1,853.5

-2.22%↓

STJ

1,193.5

-2.17%↓

HIK

1,404.5

+1.08%↑

HILS

2,490

-3.11%↓

Home・Listă Acțiuni・Haleon PLC

Haleon PLC

Deschisă

SectorSănătate

343.7 1.06

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

341.1

Maxim

343.8

Indicatori cheie
By Trading Economics
Venit	403M
Vânzări	2.7B
P/E Medie Sector	18.437 67.147
EPS	0.044
Randament dividend	2
Marjă de profit	14.708
Angajați	24,535
EBITDA	697M

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+25.61% upside

Dividende
By Dow Jones
Randament dividend Medie Sector	2.00% 2.36%
Următoarele câștiguri	30 iul. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	31B
Deschiderea anterioară	342.64
Închiderea anterioară	343.7

Sentimentul știrilor

By Acuity

31%

69%

106 / 347 Clasament în Healthcare

Haleon PLC Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

29 apr. 2026, 07:48 UTC

Câștiguri

Sensodyne-Maker Haleon Revenue Rises on Oral Health Growth -- Update

29 apr. 2026, 06:39 UTC

Câștiguri

Sensodyne-maker Haleon Revenue Rises on Oral Health Growth

25 feb. 2026, 07:55 UTC

Câștiguri

Panadol Maker Haleon Reports Revenue Slowdown Amid Weak Cold-And-Flu Season

29 apr. 2026, 08:05 UTC

Market Talk

Câștiguri

Haleon's North America Results Were Encouraging -- Market Talk

29 apr. 2026, 07:46 UTC

Market Talk

Câștiguri

Haleon's First-Quarter Results Align With Peers -- Market Talk

29 apr. 2026, 06:07 UTC

Câștiguri

Haleon: 1Q Emerging Markets Revenue Growth 4.3%

29 apr. 2026, 06:06 UTC

Câștiguri

Haleon: Q1 North America Organic Revenue Growth 1.0%

29 apr. 2026, 06:05 UTC

Câștiguri

Haleon 1Q Reported Revenue Growth 0.1%

29 apr. 2026, 06:04 UTC

Câștiguri

Analysts Saw Haleon 1Q Organic Revenue Growth 2.3%

29 apr. 2026, 06:04 UTC

Câștiguri

Haleon 1Q Organic Revenue Growth 2.2%

29 apr. 2026, 06:04 UTC

Câștiguri

Haleon 1Q Rev GBP2.86B

29 apr. 2026, 06:04 UTC

Câștiguri

Haleon Sees High-single Digit Adjusted Operating Profit Growth at Constant Currency in Medium Term

29 apr. 2026, 06:03 UTC

Câștiguri

Haleon Sees 4% to 6% Organic Rev Growth in Medium Term

29 apr. 2026, 06:03 UTC

Câștiguri

Haleon Expects a Broadly Neutral Foreign Exchange Translation Impact on Net Rev, Adj Oper Pft

29 apr. 2026, 06:02 UTC

Câștiguri

Haleon Sees 2026 Adjusted Effective Tax Rate c.24.5%

29 apr. 2026, 06:02 UTC

Câștiguri

Haleon: Sees 2026 Net Interest GBP255 Million

29 apr. 2026, 06:02 UTC

Câștiguri

Haleon Sees 2026 High-single Digit Adj Oper Pft Growth at Constant Currency

29 apr. 2026, 06:01 UTC

Câștiguri

Haleon Sees 2026 Organic Revenue Growth 3% to 5%

25 feb. 2026, 07:18 UTC

Câștiguri

Haleon 4Q Organic Revenue Growth 2.1%

25 feb. 2026, 07:17 UTC

Câștiguri

Haleon: GBP500M Allocated to Share Buybacks in 2026

25 feb. 2026, 07:16 UTC

Câștiguri

Haleon Sees 2026 High Single Digit Adj. Operating Profit Growth at Constant Currency

25 feb. 2026, 07:15 UTC

Câștiguri

Haleon Sees 2026 Organic Revenue Growth of 3% to 5%

25 feb. 2026, 07:06 UTC

Câștiguri

Haleon Declares Final Dividend of 4.9p

25 feb. 2026, 07:05 UTC

Câștiguri

Haleon 2025 Net Pft GBP1.67B

25 feb. 2026, 07:05 UTC

Câștiguri

Haleon 2025 Pretax Pft GBP2.15B

25 feb. 2026, 07:04 UTC

Câștiguri

Analysts Saw Haleon 2025 Adj Oper Pft at GBP2.46B

25 feb. 2026, 07:04 UTC

Câștiguri

Analysts Saw Haleon 2025 Adj Oper Pft Margin at 22.3%

25 feb. 2026, 07:04 UTC

Câștiguri

Analysts Saw Haleon 2025 Organic Revenue Growth at 3.4%

25 feb. 2026, 07:04 UTC

Câștiguri

Analysts Saw Haleon 2025 Rev at GBP11.03B

25 feb. 2026, 07:04 UTC

Câștiguri

Haleon 2025 Adj. Operating Pft Margin 22.9%

Comparație

Modificare preț

Haleon PLC Așteptări

Obiectiv de preț

By TipRanks

25.61% sus

Prognoză pe 12 luni

Medie 432.22 GBX 25.61%

Maxim 512 GBX

Minim 325 GBX

În baza a 9 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruHaleon PLC - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

9 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 9 analiști care au acordat evaluări ale acțiunilor Haleon PLC - Dist în ultimele 3 luni.

Sentiment

By Acuity

106 / 347 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Haleon PLC

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.